心脉医疗
(688016)
| 流通市值：129.94亿 | | | 总市值：149.34亿 |
| 流通股本：7197.81万 | | | 总股本：8272.63万 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,187,204,459.56 | 888,459,839.37 | 621,622,465.44 | 285,591,399.25 |
| 营业收入 | 1,187,204,459.56 | 888,459,839.37 | 621,622,465.44 | 285,591,399.25 |
| 二、营业总成本 | 641,267,223.89 | 453,371,586.13 | 310,393,059.06 | 145,144,980.49 |
| 营业成本 | 279,577,994.84 | 205,588,824.94 | 142,355,699.98 | 69,301,643.35 |
| 税金及附加 | 12,032,019.57 | 9,090,277 | 6,217,609.16 | 2,791,268.65 |
| 销售费用 | 130,156,250.56 | 89,121,847.65 | 63,240,684.55 | 25,073,250.27 |
| 管理费用 | 55,030,462.74 | 38,828,204.69 | 27,175,285.73 | 13,190,664.99 |
| 研发费用 | 172,884,268.43 | 117,766,098.67 | 76,385,777.34 | 36,218,269.91 |
| 财务费用 | -8,413,772.25 | -7,023,666.82 | -4,981,997.7 | -1,430,116.68 |
| 其中:利息费用 | 1,821,925.57 | 1,438,997.48 | 947,704.62 | 488,764.71 |
| 其中:利息收入 | 9,261,266.14 | 7,263,239.16 | 5,008,259.75 | 2,495,230.67 |
| 加:投资收益 | 9,148,489.85 | 5,850,521.95 | 4,296,270.61 | 2,164,491.69 |
| 资产减值损失(新) | -6,354,297.12 | -3,703,581.94 | -4,363,692.73 | -748,780.09 |
| 信用减值损失(新) | -1,336,190.64 | -3,063,482.69 | -1,788,049.41 | 43,898.83 |
| 其他收益 | 26,459,104.81 | 19,050,770.06 | 17,880,411.52 | 2,622,312.75 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 573,854,342.57 | 453,222,480.62 | 327,254,346.37 | 144,528,341.94 |
| 加:营业外收入 | 334,557.66 | 240,877.09 | 205,899.91 | 418,425.58 |
| 减:营业外支出 | 1,921,912.31 | 1,662,823.26 | 1,622,410.98 | 17,516.99 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 572,266,987.92 | 451,800,534.45 | 325,837,835.3 | 144,929,250.53 |
| 减:所得税费用 | 85,050,009.75 | 66,947,965.65 | 48,466,471.46 | 21,375,906.54 |
| 六、净利润 | 487,216,978.17 | 384,852,568.8 | 277,371,363.84 | 123,553,343.99 |
| 持续经营净利润 | 487,216,978.17 | 384,852,568.8 | 277,371,363.84 | 123,553,343.99 |
| 归属于母公司股东的净利润 | 492,431,974.71 | 388,426,350.58 | 279,526,281.09 | 124,840,722.7 |
| 少数股东损益 | -5,214,996.54 | -3,573,781.78 | -2,154,917.25 | -1,287,378.71 |
| (一)基本每股收益 | 6.81 | 5.4 | 3.88 | 1.73 |
| (二)稀释每股收益 | 6.81 | 5.4 | 3.88 | 1.73 |
| 八、其他综合收益 | -396,770.24 | -387,055.45 | -147,262.94 | 4,360.05 |
| 归属于母公司股东的其他综合收益 | -396,770.24 | -387,055.45 | -147,262.94 | 4,360.05 |
| 九、综合收益总额 | 486,820,207.93 | 384,465,513.35 | 277,224,100.9 | 123,557,704.04 |
| 归属于母公司股东的综合收益总额 | 492,035,204.47 | 388,039,295.13 | 279,379,018.15 | 124,845,082.75 |
| 归属于少数股东的综合收益总额 | -5,214,996.54 | -3,573,781.78 | -2,154,917.25 | -1,287,378.71 |
| 公告日期 | 2024-03-28 | 2023-10-28 | 2023-08-26 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |